Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912].

Autor: Iacovino ML; National Cancer Institute, IRCCS Fondazione G.Pascale, Naples, Italy., Celant S; Italian Medicines Agency, Rome, Italy., Tomassini L; Italian Medicines Agency, Rome, Italy., Arenare L; National Cancer Institute, IRCCS Fondazione G.Pascale, Naples, Italy., Caglio A; Department of Oncology, University, Ordine Mauriziano Hospital Umberto I, Turin, Italy., Canciello A; National Cancer Institute, IRCCS Fondazione G.Pascale, Naples, Italy., Salerno F; Department of Oncology, University, Ordine Mauriziano Hospital Umberto I, Turin, Italy., Olimpieri PP; Italian Medicines Agency, Rome, Italy., Di Segni S; Italian Medicines Agency, Rome, Italy., Sferrazza A; Italian Medicines Agency, Rome, Italy., Piccirillo MC; National Cancer Institute, IRCCS Fondazione G.Pascale, Naples, Italy., Domenico Beretta G; Medical Oncology, Hospital, Pescara, Italy., Pinto C; Medical Oncology, Comprehensive Cancer Centre, AUSL-IRCCS di Reggio Emilia, Italy., Blasi L; Medical Oncology, Civic Hospital Cristina Benfratelli, Palermo, Italy., Cinieri S; Medical Oncology and Breast Unit, Perrino Hospital, Brindisi, Italy., Cavanna L; Medical Oncology and Hematology, Civil Hospital, Piacenza, Italy., Di Maio M; Department of Oncology, University of Turin, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Russo P; Italian Medicines Agency, Rome, Italy., Perrone F; National Cancer Institute, IRCCS Fondazione G.Pascale, Naples, Italy.
Jazyk: angličtina
Zdroj: The Lancet regional health. Europe [Lancet Reg Health Eur] 2024 Jun 24; Vol. 42, pp. 100973. Date of Electronic Publication: 2024 Jun 24 (Print Publication: 2024).
DOI: 10.1016/j.lanepe.2024.100973
Abstrakt: [This corrects the article DOI: 10.1016/j.lanepe.2024.100912.].
(© 2024 The Author(s).)
Databáze: MEDLINE
Externí odkaz: